|
1
|
Prince M, Bryce R and Ferri CA: World
Alzheimer Report 2011: The Benefits of Early Diagnosis and
Intervention. Alzheimer's Disease International; London: pp. 1–72.
2011
|
|
2
|
Bassil N and Grossberg GT: Novel regimens
and delivery systems in the pharmacological treatment of
Alzheimer's disease. CNS Drugs. 23:293–307. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Neugroschl J and Sano M: An update on
treatment and prevention strategies for Alzheimer's disease. Curr
Neurol Neurosci Rep. 9:368–376. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ballatore C, Lee VM and Trojanowski JQ:
Tau-mediated neurodegeneration in Alzheimer's disease and related
disorders. Nat Rev Neurosci. 8:663–672. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Giacobini E and Becker RE: One hundred
years after the discovery of Alzheimer's disease. A turning point
for therapy? J Alzheimers Dis. 12:37–52. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pallàs M and Camins A: Molecular and
biochemical features in Alzheimer's disease. Curr Pharm Des.
12:4389–4408. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takashima A: Tau aggregation is a
therapeutic target for Alzheimer's disease. Curr Alzheimer Res.
7:665–669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gong CX and Iqbal K: Hyperphosphorylation
of micro-tubule-associated protein tau: A promising therapeutic
target for Alzheimer disease. Curr Med Chem. 15:2321–2328. 2008.
View Article : Google Scholar
|
|
9
|
Iqbal K, Liu F, Gong CX and Grundke-Iqbal
I: Tau in Alzheimer disease and related tauopathies. Curr Alzheimer
Res. 7:656–664. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Alonso AC, Mederlyova A, Novak M,
Grundke-Iqbal I and Iqbal K: Promotion of hyperphosphorylation by
frontotemporal dementia tau mutations. J Biol Chem.
279:34873–34881. 2004. View Article : Google Scholar
|
|
11
|
Zheng WH, Bastianetto S, Mennicken F, Ma W
and Kar S: Amyloid beta peptide induces tau phosphorylation and
loss of cholinergic neurons in rat primary septal cultures.
Neuroscience. 115:201–211. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Giacobini E and Gold G: Alzheimer disease
therapy - moving from amyloid-β to tau. Nat Rev Neurol. 9:677–686.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stoothoff WH and Johnson GV: Tau
phosphorylation: physiological and pathological consequences.
Biochim Biophys Acta. 1739:280–297. 2005. View Article : Google Scholar
|
|
14
|
Wang JZ, Grundke-Iqbal I and Iqbal K:
Kinases and phosphatases and tau sites involved in Alzheimer
neurofibrillary degeneration. Eur J Neurosci. 25:59–68. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Engmann O and Giese KP: Crosstalk between
Cdk5 and GSK3β: Implications for Alzheimer's disease. Front Mol
Neurosci. 2:22009. View Article : Google Scholar
|
|
16
|
Tsai LH, Lee MS and Cruz J: Cdk5, a
therapeutic target for Alzheimer's disease? Biochim Biophys Acta.
1697:137–142. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Piedrahita D, Hernández I, López-Tobón A,
Fedorov D, Obara B, Manjunath BS, Boudreau RL, Davidson B, Laferla
F, Gallego-Gómez JC, et al: Silencing of CDK5 reduces
neurofibrillary tangles in transgenic Alzheimer's mice. J Neurosci.
30:13966–13976. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Angelo M, Plattner F and Giese KP:
Cyclin-dependent kinase 5 in synaptic plasticity, learning and
memory. J Neurochem. 99:353–370. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Alvarez A, Muñoz JP and Maccioni RB: A
Cdk5-p35 stable complex is involved in the beta-amyloid-induced
deregulation of Cdk5 activity in hippocampal neurons. Exp Cell Res.
264:266–274. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Noble W, Olm V, Takata K, Casey E, Mary O,
Meyerson J, Gaynor K, LaFrancois J, Wang L, Kondo T, et al: Cdk5 is
a key factor in tau aggregation and tangle formation in vivo.
Neuron. 38:555–565. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Utreras E, Maccioni R and
González-Billault C: Cycl-in-dependent kinase 5 activator p35
over-expression and amyloid beta synergism increase apoptosis in
cultured neuronal cells. Neuroscience. 161:978–987. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dhavan R and Tsai LH: A decade of CDK5.
Nat Rev Mol Cell Biol. 2:749–759. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nikkel AL, Martino B, Markosyan S,
Brederson JD, Medeiros R, Moeller A and Bitner RS: The novel
calpain inhibitor A-705253 prevents stress-induced tau
hyperphosphorylation in vitro and in vivo. Neuropharmacology.
63:606–612. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rao MV, McBrayer MK, Campbell J, Kumar A,
Hashim A, Sershen H, Stavrides PH, Ohno M, Hutton M and Nixon RA:
Specific calpain inhibition by calpastatin prevents tauopathy and
neurodegeneration and restores normal lifespan in tau P301L mice. J
Neurosci. 34:9222–9234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Orsolić N, Knezević AH, Sver L, Terzić S
and Basić I: Immunomodulatory and antimetastatic action of propolis
and related polyphenolic compounds. J Ethnopharmacol. 94:307–315.
2004. View Article : Google Scholar
|
|
26
|
Gulati N, Laudet B, Zohrabian VM, Murali R
and Jhanwar-Uniyal M: The antiproliferative effect of quercetin in
cancer cells is mediated via inhibition of the PI3K-Akt/PKB
pathway. Anticancer Res. 26(2A): 1177–1181. 2006.PubMed/NCBI
|
|
27
|
Landis-Piwowar KR, Milacic V and Dou QP:
Relationship between the methylation status of dietary flavonoids
and their growth-inhibitory and apoptosis-inducing activities in
human cancer cells. J Cell Biochem. 105:514–523. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mahoney SE, Davis JM, Murphy EA, McClellan
JL and Pena MM: Dietary quercetin reduces chemotherapy-induced
fatigue in mice. Integr Cancer Ther. 13:417–424. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chondrogianni N, Kapeta S, Chinou I,
Vassilatou K, Papassideri I and Gonos ES: Anti-ageing and
rejuvenating effects of quercetin. Exp Gerontol. 45:763–771. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ferri P, Angelino D, Gennari L, Benedetti
S, Ambrogini P, Del Grande P and Ninfali P: Enhancement of
flavonoid ability to cross the blood-brain barrier of rats by
co-administration with α-tocopherol. Food Funct. 6:394–400. 2015.
View Article : Google Scholar
|
|
31
|
Li Y, Zhou S, Li J, Sun Y, Hasimu H, Liu R
and Zhang T: Quercetin protects human brain microvascular
endothelial cells from fibrillar β-amyloid1-40-induced toxicity.
Acta Pharm Sin B. 5:47–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ishisaka A, Mukai R, Terao J, Shibata N
and Kawai Y: Specific localization of quercetin-3-O-glucuronide in
human brain. Arch Biochem Biophys. 557:11–17. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Faria A, Pestana D, Teixeira D, Azevedo J,
De Freitas V, Mateus N and Calhau C: Flavonoid transport across
RBE4 cells: a blood-brain barrier model. Cell Mol Biol Lett.
15:234–241. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li H, Liu Y, Yi Y, Miao Q, Liu S, Zhao F,
Cong W, Wang C and Xia C: Purification of quercetin-3-O-sophoroside
and isoquercitrin from Poacynum hendersonii leaves using
macroporous resins followed by Sephadex LH-20 column
chromatography. J Chromatogr B Analyt Technol Biomed Life Sci.
1048:56–63. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang SH, Wang SQ, Liu CH and Yang YH:
Studies on quality standards for Pollen Typhae(puhuang). Zhongguo
Zhong Yao Za Zhi. 25:136–139. 2000.In Chinese.
|
|
36
|
Ansari MA, Abdul HM, Joshi G, Opii WO and
Butterfield DA: Protective effect of quercetin in primary neurons
against Aβ(1-42): relevance to Alzheimer's disease. J Nutr Biochem.
20:269–275. 2009. View Article : Google Scholar
|
|
37
|
Rezai-Zadeh K, Arendash GW, Hou H,
Fernandez F, Jensen M, Runfeldt M, Shytle RD and Tan J: Green tea
epigallo-catechin-3-gallate (EGCG) reduces beta-amyloid mediated
cognitive impairment and modulates tau pathology in Alzheimer
transgenic mice. Brain Res. 1214:177–187. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Devi L and Ohno M: 7,8-Dihydroxyflavone, a
small-molecule TrkB agonist, reverses memory deficits and BACE1
elevation in a mouse model of Alzheimer's disease.
Neuropsychopharmacology. 37:434–444. 2012. View Article : Google Scholar :
|
|
39
|
Spencer JP: The impact of flavonoids on
memory: physiological and molecular considerations. Chem Soc Rev.
38:1152–1161. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Oishi K and Lyketsos CG: Alzheimer's
disease and the fornix. Front Aging Neurosci. 6:2412014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shi Y: Serine/threonine phosphatases:
Mechanism through structure. Cell. 139:468–484. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sun L, Liu SY, Zhou XW, Wang XC, Liu R,
Wang Q and Wang JZ: Inhibition of protein phosphatase 2A- and
protein phosphatase 1-induced tau hyperphosphorylation and
impairment of spatial memory retention in rats. Neuroscience.
118:1175–1182. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bennecib M, Gong CX, Grundke-Iqbal I and
Iqbal K: Inhibition of PP-2A upregulates CaMKII in rat forebrain
and induces hyperphosphorylation of tau at Ser 262/356. FEBS Lett.
490:15–22. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Martin L, Latypova X, Wilson CM,
Magnaudeix A, Perrin ML and Terro F: Tau protein phosphatases in
Alzheimer's disease: The leading role of PP2A. Ageing Res Rev.
12:39–49. 2013. View Article : Google Scholar
|
|
45
|
Tao T, He C, Deng J, Huang Y, Su Q, Peng
M, Yi M, Darko KO, Zou H and Yang X: A novel synthetic derivative
of quercetin,
8-trifluoromethyl-3,5,7,3′,4′-O-pentamethyl-quercetin, inhibits
bladder cancer growth by targeting the AMPK/mTOR signaling pathway.
Oncotarget. 8:71657–71671. 2017.PubMed/NCBI
|
|
46
|
Luo T, Jiang W, Kong Y, Li S, He F, Xu J
and Wang HQ: The protective effects of jatrorrhizine on
β-amyloid(25–35)-induced neurotoxicity in rat cortical neurons. CNS
Neurol Disord Drug Targets. 11:1030–1037. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Luo T, Zhang H, Zhang WW, Huang JT, Song
EL, Chen SG, He F, Xu J and Wang HQ: Neuroprotective effect of
Jatrorrhizine on hydrogen peroxide-induced cell injury and its
potential mechanisms in PC12 cells. Neurosci Lett. 498:227–231.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu J, Li L and Suo WZ: HT22 hippocampal
neuronal cell line possesses functional cholinergic properties.
Life Sci. 84:267–271. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen X, Huang T, Zhang J, Song J, Chen L
and Zhu Y: Involvement of calpain and p25 of CDK5 pathway in
ginsenoside Rb1's attenuation of β-amyloid
peptide25–35-induced tau hyperphosphorylation in
cortical neurons. Brain Res. 1200:99–106. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang JZ, Wang ZH and Tian Q: Tau
hyperphosphorylation induces apoptotic escape and triggers
neurodegeneration in Alzheimer's disease. Neurosci Bull.
30:359–366. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Shukla V, Seo J, Binukumar BK, Amin ND,
Reddy P, Grant P, Kuntz S, Kesavapany S, Steiner J, Mishra SK, Tsai
LH and Pant HC: TFP5, a peptide inhibitor of aberrant and
hyperactive Cdk5/p25, attenuates pathological phenotypes and
restores synaptic function in CK-p25Tg mice. J Alzheimers Dis.
56:335–349. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zukerberg LR, Patrick GN, Nikolic M,
Humbert S, Wu CL, Lanier LM, Gertler FB, Vidal M, Van Etten RA and
Tsai LH: Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine
phosphorylation, kinase upregulation, and neurite outgrowth.
Neuron. 26:633–646. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Pievani M, de Haan W, Wu T, Seeley WW and
Frisoni GB: Functional network disruption in the degenerative
dementias. Lancet Neurol. 10:829–843. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kimura T, Ishiguro K and Hisanaga S:
Physiological and pathological phosphorylation of tau by Cdk5.
Front Mol Neurosci. 7:652014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kawahara M and Kuroda Y: Intracellular
calcium changes in neuronal cells induced by Alzheimer's
beta-amyloid protein are blocked by estradiol and cholesterol. Cell
Mol Neurobiol. 21:1–13. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kusakawa G, Saito T, Onuki R, Ishiguro K,
Kishimoto T and Hisanaga S: Calpain-dependent proteolytic cleavage
of the p35 cyclin-dependent kinase 5 activator to p25. J Biol Chem.
275:17166–17172. 2000. View Article : Google Scholar : PubMed/NCBI
|
